InterventionsHumans

Real-World Effectiveness of GLP-1 Receptor Agonists on Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF).

AHA Scientific Sessions 2025 Abstract

The paper

Cheryl Kalapura, Jiwon Shin, Robert John Mentz,

Stephen John Greene, Brian Mac Grory, Fan Li, Jay B. Lusk,

Emily Claire O'Brien

Duke University

AHA Scientific Sessions 2025 Abstract · 3 Nov 2025

Presented at AHA Scientific Sessions 2025 · Abstract 4370283

doi.org/10.1161/circ.152.suppl_3.4370283

Semaglutide improved heart artery function in pigs
Research Square · 8 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease
The American Journal of Cardiology · 8 Oct 2026